2020-11-13T07:07:41-06:00 2019-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2019-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 2027838700 2020-11-09 1 YUNG-HEE GALLINARO P00035293 5712279500 2020-11-09 108.48.156.67 2020-11-09 07:36:22 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 87826B80F82B7742AC94E6ED7EC5993094E974B0 2019 2021-04-22 16:20:28Z ADVAMED SCOTT WHITAKER 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 43356283 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS & DEVICE MANUFACTURERS ON REGULATORY & LEGISLATIVE ISSUES. 50 50 115 51 4233 1483 0 0 41086208 43045863 201580 272200 56685 38220 41344473 43356283 232500 271000 0 0 22243762 23329188 0 0 0 18686555 18738061 41162817 42338249 181656 1018034 18080233 20575198 10683854 12147131 7396379 8428067 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 103 0 115 1 1 1 1 JA CH 0 0 0 0 1 0 X 50 50 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X JENNIFER BREAREY 2027838700 701 PENNSYLVANIA AVE NW SUITE 800 WASHINGTON DC 200042654 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 40.00 X 2079835 0 63188 CHRISTOPHER L WHITE EVP, GENERAL COUNSEL 40.00 X 754050 0 60921 ANDREW FISH CHIEF STRATEGY OFFICER 40.00 X 689628 0 60888 GREG CRIST CHIEF ADVOCACY OFF. HEAD OF EXT. AFFAIRS 40.00 X 570983 0 63188 JANET TRUNZO EVP, TECH AND REGULATORY AFFAIRS 40.00 X 565081 0 43187 RAY BRISCUSO EVP, CONFERENCES & EVENTS 40.00 X 539324 0 50522 RALPH IVES EVP, GLOBAL STRATEGY 40.00 X 507984 0 33448 DONALD MAY EVP, PMT & HEALTH CARE DELIVERY POLICY 40.00 X 484631 0 50522 SUSAN VAN METER EXECUTIVE DIRECTOR, ADVAMED DX 40.00 X 421912 0 33763 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 40.00 X 375499 0 55445 ASHLEY WITTORF EXEC. DIRECTOR, ADVAMED ACCEL 40.00 X 357838 0 55445 STEVEN BROTMAN SVP, PMT & HEALTH CARE DELIVERY POLICY 40.00 X 375910 0 24277 RICHARD PRICE EVP, PUBLIC AFFAIRS 40.00 X 357280 0 42441 KEVIN LOBO CHAIRPERSON 1.00 X X 0 0 0 WALTER ROSEBROUGH TREASURER 1.00 X X 0 0 0 PETER ARDUINI SECRETARY 1.00 X X 0 0 0 NACHO ABIA DIRECTOR 1.00 X 0 0 0 GIUSEPPE ACCOGLI DIRECTOR 1.00 X 0 0 0 SCOTT BROOKS DIRECTOR 1.00 X 0 0 0 DOUG BRYANT DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR 1.00 X 0 0 0 ROLAND DIGGELMANN DIRECTOR 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 DENNIS DURMIS DIRECTOR 1.00 X 0 0 0 LISA EARNHARDT DIRECTOR 1.00 X 0 0 0 DAVID ENDICOTT DIRECTOR 1.00 X 0 0 0 CAMILLE FARHAT DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 JASON FIELD DIRECTOR 1.00 X 0 0 0 VINCENT FORLENZA DIRECTOR 1.00 X 0 0 0 TODD FRUCHTERMAN DIRECTOR 1.00 X 0 0 0 ANTOINETTE GAWIN DIRECTOR 1.00 X 0 0 0 JOHN GROETELAARS DIRECTOR 1.00 X 0 0 0 BRYAN HANSON DIRECTOR 1.00 X 0 0 0 THOMAS KAPFER DIRECTOR 1.00 X 0 0 0 LIAM KELLY DIRECTOR 1.00 X 0 0 0 JOHN LIDDICOAT DIRECTOR 1.00 X 0 0 0 MICHAEL LYNCH DIRECTOR 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 V GEORGE MALIEKEL DIRECTOR 1.00 X 0 0 0 CAREN MASON DIRECTOR 1.00 X 0 0 0 STEPHEN MASON DIRECTOR 1.00 X 0 0 0 DAMIEN MCDONALD DIRECTOR 1.00 X 0 0 0 ASHLEY MCEVOY DIRECTOR 1.00 X 0 0 0 THOMAS MCGUINNESS DIRECTOR 1.00 X 0 0 0 BRIAN MILLER DIRECTOR 1.00 X 0 0 0 MICHAEL MINOGUE DIRECTOR 1.00 X 0 0 0 JEFF MIRVISS DIRECTOR 1.00 X 0 0 0 MICHAEL MUSSALLEM DIRECTOR 1.00 X 0 0 0 CAROLL NEUBAUER DIRECTOR 1.00 X 0 0 0 DAVID PACITTI DIRECTOR 1.00 X 0 0 0 KEN REALI DIRECTOR 1.00 X 0 0 0 VITOR ROCHA DIRECTOR 1.00 X 0 0 0 MATTHEW SAUSE DIRECTOR 1.00 X 0 0 0 SCOTT SCHORER DIRECTOR 1.00 X 0 0 0 MARTHA SHADAN DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 KRISTIAN VILLUMSEN DIRECTOR 1.00 X 0 0 0 THOMAS WEST DIRECTOR 1.00 X 0 0 0 DOW WILSON DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 NADIM YARED DIRECTOR 1.00 X 0 0 0 JORGEN HANSEN DIRECTOR 1.00 X 0 0 0 8079955 0 637235 54 0 1 0 ADFERO GROUP LLC 1666 K STREET NW SUITE 250 5TH F WASHINGTON DC 20006 PUBLIC RELATION CONSULTING 721974 BROWNSTEIN HYATT FARBER SCHRECK LLP TOT 410 SEVENTEENTH STREET SUITE 2200 DENVER CO 80202 CONSULTING SERVICES MDT 500000 THE BOSTON CONVENTION AND EXHBITION CENT 980 N MICHIGAN AVE CHICAGO IL 60611 FOOD/BEVERIDGE FOR MTC 480537 FREEMAN DECORATING CO TOTAL 1000 ELMWOOD PARK BLVD NEW ORLEANS LA 70123 DECORATION SERVICES 367797 NIMBLEUSER TOTAL 1100 PITTSFORD VICTOR ROAD PITTSFORD NY 14534 CRM 367200 41 MEMBERSHIP DUES 900099 35715578 35715578 MEETINGS & SEMINARS 611430 6566449 6566449 ASSESSMENTS 900099 763836 763836 43045863 272200 272200 33987 33987 JOB BOARD REVENUE 900099 4233 4233 4233 43356283 43045863 4233 306187 X 271000 6360579 13658072 1001018 1336561 972958 739452 50491 3881373 4963517 10472 1127452 86357 2133467 1049757 3352579 525800 105417 DUES AND SUBSCRIPTIONS 447910 TRAINING 69256 194761 42338249 395 396 11212984 13259936 791161 845316 694845 892928 7286952 6409721 778308 877231 1577253 1779810 2993590 2860513 31697 59068 18080233 20575198 5257446 6639976 1713070 1470663 3713338 4036492 10683854 12147131 X 7396379 8428067 7396379 8428067 18080233 20575198 X 1018034 13654 X 0 1 X 1 0 0 0 1 32676047 3881373 -1065423 2815950 3657605 -841655 3219368 2889565 329803 1087848 972332 115516 2979736 2547824 431912 877231 DEFERRED RENT 529442 DEFERRED COMPENSATION 1779810 DEFERRED TENANT ALLOWANCE 300648 DEFERRED ASSESSMENTS 1426592 4036492 X PART X, LINE 2: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS EXEMPT FROM U.S. INCOME TAXES UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE (IRC). THE ASSOCIATION IS NOT EXEMPT FROM U.S. INCOME TAXES ON INCOME FROM ANY UNRELATED BUSINESS ACTIVITIES. ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 3 12 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1682303 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 102796 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 5 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 334215 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 102663 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 19216 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 3681 SOUTH AMERICA 0 2 PROGRAM SERVICES CONSULTANT IN BRAZIL MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 373052 SOUTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 58777 SOUTH ASIA 0 2 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 426182 SOUTH ASIA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 26857 3 19 0 2 3 21 2676703 453039 3129742 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 RESEARCHAMERICA 241 18TH STREET SOUTH STE 501 ARLINGTON VA 22202 521609875 501(C)(3) 35000 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 750 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 541379174 501(C)(3) 35000 PROGRAM SUPPORT UNITED SPINAL ASSOCIATION 120-34 QUEENS BLVD STE 320 KEW GARDEN NY 11415 135612621 501(C)(3) 30000 PROGRAM SUPPORT AMERICAN CANCER SOCIETY CANCER ACTION NETWORK 555 11TH STREET SUITE 300 WASHINGTON DC 20036 522340031 501(C)(3) 25000 PROGRAM SUPPORT JUVENILE DIABETES RESEARCH FOUNDATION (JDRF) 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 510150028 501(C)(3) 20000 PROGRAM SUPPORT SOCIETY FOR WOMENS HEALTH RESEARCH 1025 CONNECTICUT AVENUE NW SUITE 601 WASHINGTON DC 20036 520150028 501(C)(3) 15000 PROGRAM SUPPORT AIDS INSTITUTE INC 17 DAVIS BOULEVARD SUITE 403 TAMPA FL 33606 650380952 501(C)(3) 10000 PROGRAM SUPPORT LUNGEVITY FOUNDATION 228 SOUTH WABASH AVENUE SUITE 700 CHICAGO IL 60604 364433410 501(C)(3) 10000 PROGRAM SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 10000 PROGRAM SUPPORT SPINA BIFIDA-ASSOCIATION OF AMERICA 1600 WILSON BLVD ARLINGTON VA 22209 581342181 501(C)(3) 10000 PROGRAM SUPPORT HEALTHY WOMEN 1 HARDING ROAD SUITE 102 RED BANK NJ 07701 521624846 501(C)(3) 10000 PROGRAM SUPPORT THE NATIONAL ITALIAN AMERICAN FOUNDATION 1860 19TH STREET NW WASHINGTON DC 20009 521071723 501(C)(3) 10000 PROGRAM SUPPORT EVERYLIFE FOUNDATION 1012 14TH STREET NW STE 500 WASHINGTON DC 20005 264614274 501(C)(3) 5500 PROGRAM SUPPORT 13 PART I LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X 0 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 1015792 0 1064043 0 0 0 32413 0 30775 0 2143023 0 0 0 CHRISTOPHER L WHITE EVP, GENERAL COUNSEL 638193 0 115857 0 0 0 32413 0 28508 0 814971 0 0 0 ANDREW FISH CHIEF STRATEGY OFFICER 611703 0 77925 0 0 0 30113 0 30775 0 750516 0 0 0 GREG CRIST CHIEF ADVOCACY OFF. HEAD OF EXT. AFF 492483 0 78500 0 0 0 32413 0 30775 0 634171 0 0 0 JANET TRUNZO EVP, TECH AND REGULATORY AFFAIRS 483796 0 81285 0 0 0 32413 0 10774 0 608268 0 0 0 RAY BRISCUSO EVP, CONFERENCES & EVENTS 411324 0 128000 0 0 0 32413 0 18109 0 589846 0 0 0 RALPH IVES EVP, GLOBAL STRATEGY 439019 0 68965 0 0 0 32413 0 1035 0 541432 0 0 0 DONALD MAY EVP, PMT & HEALTH CARE DELIVERY POLI 432266 0 52365 0 0 0 32413 0 18109 0 535153 0 0 0 SUSAN VAN METER EXECUTIVE DIRECTOR, ADVAMED DX 367750 0 54162 0 0 0 32413 0 1350 0 455675 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 324954 0 50545 0 0 0 32413 0 23032 0 430944 0 0 0 ASHLEY WITTORF EXEC. DIRECTOR, ADVAMED ACCEL 316175 0 41663 0 0 0 32413 0 23032 0 413283 0 0 0 STEVEN BROTMAN SVP, PMT & HEALTH CARE DELIVERY POLI 361144 0 14766 0 0 0 18046 0 6231 0 400187 0 0 0 RICHARD PRICE EVP, PUBLIC AFFAIRS 317273 0 40007 0 0 0 32413 0 10028 0 399721 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE CEO OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. FORM 990, PART VI, SECTION A, LINE 1 THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIRMAN, THE ADVAMED-DX CHAIRMAN, AND NOT FEWER THAN FIVE NOR MORE THAN TEN MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL OFFICER AND CONTROLLER PERFORM AN INDEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE, AUDIT AND COMPENSATION COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THE PROCESS RECENTLY TOOK PLACE IN 2019. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 4,963,517. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP 13,654. MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 364725626 TRADE SHOW DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVAMED PURCHASING GROUP INC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 812764022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1